ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
DSM has presented a new five-year plan designed to carry it through to 2010. In contrast with a similar plan in 2000, DSM Chairman Peter Elver-ding sees no radical reshaping. The company plans, instead, to build on existing strengths to get a targeted 3–5% annual sales growth rate. Among its goals for 2010 are a doubling of sales in China to some $1.2 billion a year and more than $1 billion in annual sales from innovative products, particularly in the areas of biomedical materials, specialty packaging, personalized nutrition, and industrial biotechnology. DSM will also establish a new innovation center in Heerlen, the Netherlands, to be staffed with 250 full-time-equivalent positions.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X